---
figid: PMC5564615__oncotarget-08-47916-g007
figtitle: Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent
  pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC5564615
filename: oncotarget-08-47916-g007.jpg
figlink: /pmc/articles/PMC5564615/figure/F7/
number: F7
caption: Model showing that MDM2 is a central hub in estrogen signaling and works
  through an Rb-E2F1 pathway to promote proliferation. Breast cancer cells harboring
  SNP309 have increased binding of the transcription factor Sp1, which causes elevated
  MDM2 protein levels. Fulvestrant blocks the MDM2 pathway and the Rb-E2F1 pathway.
papertitle: Estrogen-activated MDM2 disrupts mammary tissue architecture through a
  p53-independent pathway.
reftext: Nandini Kundu, et al. Oncotarget. 2017 Jul 18;8(29):47916-47930.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9517416
figid_alias: PMC5564615__F7
figtype: Figure
redirect_from: /figures/PMC5564615__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5564615__oncotarget-08-47916-g007.html
  '@type': Dataset
  description: Model showing that MDM2 is a central hub in estrogen signaling and
    works through an Rb-E2F1 pathway to promote proliferation. Breast cancer cells
    harboring SNP309 have increased binding of the transcription factor Sp1, which
    causes elevated MDM2 protein levels. Fulvestrant blocks the MDM2 pathway and the
    Rb-E2F1 pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SP1
  - PSG1
  - DAND5
  - E2F1
  - UBE2L3
  - MDM2
  - RB1
  - sp1
  - e2f1
  - mdm2
---
